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Abstract 
This study investigated the effects of a pragmatic lifestyle intervention in obese adults with 
continuous positive airway pressure-treated obstructive sleep apnoea hypopnoea syndrome 
(OSAHS). 
Sixty patients were randomised 1:1 to either a 12-week lifestyle intervention or an advice-
only control group. The intervention involved supervised exercise sessions, dietary advice 
and the promotion of lifestyle behaviour change using cognitive-behavioural techniques. 
Outcomes were assessed at baseline (week 0), intervention end-point (week 13) and follow-
up (week 26). The primary outcome was 13-week change in body mass. Secondary 
outcomes included anthropometry, blood-borne biomarkers, exercise capacity, and health-
related quality of life.  
At end-point, the intervention group exhibited small reductions in body mass (-1.8 [-3.0, -
0.5] kg; P=0.007) and body fat percentage (-1 [-2, 0] %; P=0.044) and moderate 
improvements in C-reactive protein (-1.3 [-2.4, -0.2] mg⋅L-1, P=0.028) and exercise capacity 
(95 [50, 139] m; P<0.001). At follow-up, changes in body mass (-2.0 [-3.5, -0.5] kg; P=0.010), 
body fat percentage (-1 [-2, 0] %; P=0.033) and C-reactive protein (-1.3 [-2.5, -0.1] mg⋅L-1; 
P=0.037) were maintained and exercise capacity was further improved (132 [90, 175] m; 
P<0.001). 
These findings suggest that a 12-week pragmatic lifestyle intervention can improve 
important cardiometabolic outcomes in obese adults with treated OSAHS. 
 
 
 
ClinicalTrials.gov identifier: NCT01546792 
Introduction 
Obstructive sleep apnoea hypopnoea syndrome (OSAHS) is the most common form of sleep-
disordered breathing, characterised by repetitive nocturnal airway obstruction and frequent 
nocturnal arousals from sleep that lead to excessive daytime sleepiness (EDS). Prevalence 
surveys suggest that 2% of women and 4% of men at middle age are affected by this 
syndrome, which is becoming increasingly common with the current obesity epidemic 
(Young et al., 2002). The clinical consequences of repeated airway closures (hypoxaemia, 
sympathoexcitation and oxidative stress) contribute to the premature development of 
cardiovascular disease, specifically ischaemic heart disease, stroke and hypertension. 
Individuals with OSAHS are frequently obese (Young et al., 2008) and physically inactive 
(Peppard and Young, 2004), and epidemiological data indicate an independent relationship 
between OSAHS and cardiovascular disease (Bradley and Floras, 2009). Obesity is a key 
modifiable risk factor for OSAHS (Jordan et al., 2014) with, recent guidelines suggesting that 
all overweight and obese patients with OSAHS be encouraged to lose weight (Qaseem et al., 
2013). As both untreated OSAHS and obesity contribute to the increased morbidity and 
mortality, interventions capable of addressing both should be considered. 
Continuous positive airway pressure (CPAP), the a primary therapy for moderate-to-severe 
OSAHS, improves subjective and objective measures of sleepiness (Giles et al., 2006) but 
provides only day-to-day management of the condition, not a long term cure (i.e. 
withdrawal of CPAP causes symptoms to return). Moreover, CPAP has minimal effects on 
patieŶts’ ǁeight or phǇsiĐal aĐtiǀitǇ leǀels ;West et al., 2009) despite increasing exercise 
capacity (Billings et al., 2013). In contrast, intensive lifestyle interventions, which typically 
involve very low energy diets (VLEDs), appear to be effective for initial rapid weight 
reduction and can sometimes result in complete remission of OSAHS (Johansson et al., 
2011; Thomasouli et al., 2013), although steady post-intervention weight regain is common 
(Kajaste et al., 2004; Barnes et al., 2009). However, intensive lifestyle interventions are 
limited in that they might not be acceptable to many patients or deliverable within a tax-
funded healthcare system. Further research is needed to explore the impact of lower-
intensity (i.e. more practical) lifestyle interventions on body mass (i.e. weight) and other 
important health outcomes in overweight and obese individuals with OSAHS. 
We conducted a randomised controlled trial to determine the impact of a 12-week 
pragmatic lifestyle intervention on body mass and other indicators of health and fitness in 
obese adults who were currently being treated with CPAP for moderate-to-severe OSAHS. 
The pragmatic lifestyle intervention incorporated supervised exercise sessions, dietary 
education and advice, and the promotion of lifestyle behaviour change using cognitive-
behavioural techniques. We hypothesised that the intervention group would have greater 
improvement in body mass and other cardiometabolic outcomes, compared with an advice-
only control group. 
 
Materials and methods 
Participants 
Patients with OSAHS were recruited from sleep clinics at Sheffield Teaching Hospitals NHS 
Foundation Trust. Eligible patients ǁere oďese ;ďodǇ ŵass iŶdeǆ ;BMIͿ >ϯϬ kg∙ŵ-2) men and 
women aged 18-85 years with at least moderate OSAHS (apnoea hypopnoea index (AHI) > 
15 eǀeŶts∙h-1; oxygen desaturatioŶ iŶdeǆ > ϭϱ eǀeŶts∙h-1; Epworth Sleepiness Scale (ESS) 
>11) treated with CPAP therapy. Adherence was assessed subjectively using self-report 
during history-taking (>75% nightly use; >4 hours per night) and objectively by percentage 
nights CPAP was used, combined with indices of treatment efficacy (i.e. normalisation of AHI 
and ESS). Exclusion criteria were any contraindications to exercise testing and training such 
as severe hypertension, unstable angina, uncontrolled cardiac arrhythmias, an inability or 
unwillingness to undertake the commitments of the study or participation in regular 
purposeful eǆerĐise ;>ϯϬ ŵiŶ, ≥ϯ tiŵes per ǁeek; self-reported). The study was approved by 
the South Yorkshire Research Ethics Committee (09/H1310/74) and all participants provided 
written informed consent prior to enrolment. 
Sample size 
The primary outcome measure was body mass (at intervention end-point) because weight 
loss is a key focus of management guidelines for overweight and obese individuals with 
OSAHS (Qaseem et al., 2013), and previous studies have shown reductions in body mass 
correlate with improvements in severity of OSAHS (Johansson et al., 2011; Fredheim et al., 
2013). A total of 60 participants (30 participants per group) were required to detect a 
between-group difference of at least 1.5 kg at intervention end-point, assuming a standard 
deviation of 12 kg for body mass (Tuomilehto et al., 2010), a pre-post correlation for body 
mass of 0.991 (Healy et al., 2013), 20% attrition, 90% power, and a 2-tailed alpha of 0.05. 
Design and randomisation 
This was a non-blinded, parallel-group, randomised controlled trial. Participants were 
allocated 1:1 to either a 12-week pragmatic lifestyle intervention or an advice-only control 
group using a randomisation sequence created by an independent researcher prior to 
recruitment (nQuery, Statistical Solutions, USA). The research team were notified of group 
allocation once each participant completed their baseline assessment. Outcome measures 
were assessed before randomisation (week 0), at intervention end-point (week 13), and 
after 13 weeks of independence (week 26). 
 
Pragmatic lifestyle intervention 
Participants randomised to the pragmatic lifestyle intervention were invited to attend 
supervised exercise sessions at a University exercise facility within one mile of the treating 
hospital. The frequency of exercise sessions was initially three per week. This was reduced 
to two per week during weeks 5 to 8 (with a third exercise session being undertaken 
independently by participants at their convenience) and then to one per week (with two 
self-directed exercise sessions) during weeks 9 to 12. This pattern was designed to gradually 
decrease dependence on our facility, supervision and expertise and to promote participants' 
independent exercise participation, which was reported in an exercise diary. Exercise 
sessions lasted approximately one hour and typically comprised 45 minutes of aerobic 
interval training (treadmill walking/jogging, cycling and rowing), 15 minutes of resistance 
training (major muscle groups) and exercises aimed at improving flexibility and balance. The 
aerobic interval training involved alternating hard and easy exercise bouts at a ratio of 1:2 
(e.g. 0.5 min hard, 1 min easy), progressing to 4:1 (e.g. 4 min hard, 1 min easy) as tolerated. 
Heart rate and perceived exertion (RPE, using a 6 to 20 scale; Borg, 1982) were recorded at 
the end of hard intervals to facilitate prescription and monitor progression (RPE: 14–16 for 
hard bouts; and 9-11 for easy bouts). Exercise sessions were individualised and directed by 
an exercise physiologist taking into account participants' health, mobility and preferences. 
The cognitive-behavioural component of the intervention was integrated into exercise 
sessions and involved psycho-education (based upon attitudes, experiences, emotions, 
beliefs etc.) tailored to participants' stage of change and implemented the cognitive-
behavioural processes of change as outlined by the trans-theoretical model (Prochaska & 
Norcross, 2009). Such an approach has demonstrated efficacy in clinical populations 
previously (Daley et al., 2004). Concurrent dietary education and advice based on the 
principles of the EatWell plate model (http://www.eatwell.gov.uk) was also integrated into 
the sessions. A three-day diet diary was completed and assessed to identify dietary 
imbalance, and as a tool to set short- and long-term goals. A British Heart Foundation (BHF) 
ǁeight loss leaflet "“o… You ǁaŶt to lose ǁeight for good?" was provided and key concepts 
extracted from it. Participants allocated to the advice-only control group received a letter 
explaining their group allocation, basic written lifestyle advice and the BHF weight loss 
leaflet.  
Study outcomes 
PartiĐipaŶts’ ďodǇ ŵass ǁas ŵeasured in duplicate using a calibrated beam-balance scale 
(Model 424; Weylux; Hallamshire Scales Ltd, Sheffield, UK). Participants were minimally 
dressed and the mean of two consecutive concordant measurements was used. Secondary 
outcomes were BMI, neck, waist and hip circumferences, body fat percentage (Bodystat® 
Quadscan 4000, Bodystat ltd., IM99 1DQ), health-related quality of life using the EuroQol 
EQ5D-3L questionnaire (EuroQol Executive Office, 3068 AV Rotterdam, Netherlands) and 
exercise capacity using the incremental shuttle walking test (ISWT; Singh et al., 1992). 
Fasting venous blood was collected, centrifuged, separated and frozen for subsequent 
biochemical analysis. Full lipid profile, glucose and high-sensitivity C-reactive protein (hs-
CRP) were measured on an ADVIA 2400 and insulin concentrations on an ADVIA Centaur® XP 
(Siemens, 511 Benedict Ave / Tarrytown, NY 10591).  
 
Statistical analyses 
The mean difference in change of  body mass  between the treatment groups was assessed 
at intervention end-point (week 13) by analysis of covariance (ANCOVA) using baseline body 
mass as a covariate and change scores (end-point minus baseline) as the dependent 
variable. The adjusted mean difference in change between groups at week 13 and 
corresponding 95% confidence interval (CI) from the model are presented. All analyses were 
done on an intention-to-treat basis with previous observations carried forward where 
necessary. The same procedure was used to assess treatment difference in body mass at 
follow-up (week 26). Treatment differences for other outcomes were similarly analysed 
using separate ANCOVAs for intervention end-point (week 13) and follow-up (week 26). All 
analyses were carried out in SPSS version 18.0 (SPSS UK Ltd, 2 New Square (B3 Floor 2), 
Bedfont Lakes, TW14 8HB, UK). Statistical tests were at a two-sided 0·05 significance level. 
Analysis of residuals was undertaken for all regression models in order to assess model 
assumptions. 
 
Results 
Participant characteristics 
“iǆtǇ patieŶts ǁith ĐoŶtrolled O“AH“ ;E““: ϱ.Ϭ [ϯ.Ϭ, ϲ.ϴ]; AHI: Ϯ.ϰ [ϭ.ϵ, ϯ.Ϯ] eǀeŶts∙h-1) that 
were long-term CPAP users enrolled on the study. Due to some patients relocation from 
hospital Trusts elsewhere in the UK, CPAP start dates were only available for 75% of 
participants. For these patients, median [range] CPAP history was 1.2 [0.51-10.8] years. All 
sixty patients had a verifiable usage history of at least 6 months. Both groups were classified 
as obese, eucholesterolaemic, euglycaemic and hyperinsulinaemic. 
 
Recruitment, retention and compliance 
We invited 481 potentially eligible patients to participate in our study, of which 123 (26%) 
responded with interest and underwent further screening (Figure 1). Of these, 60 (49%) 
enrolled giving a recruitment rate of 12%. Although six participants (10%) withdrew from 
the study (unrelated health change: n=2; change in work commitments: n=2; no reason: 
n=2), 97% of assessments (157 of 162) and 96% of exercise sessions (620 of 648) were 
attended. No adverse events were recorded in more than 650 hours of exercise training. 
Baseline characteristics are summarised in Table 1. 
 
 
Figure 1: CONSORT flow-chart 
 
 
Anthropometrics 
End-point and follow-up data for anthropometric outcomes are presented in Table 2. The 
adjusted mean difference in change in body mass at intervention end-point (primary 
outcome) was -1.8 [-3.0, -0.5] kg (P=0.007), favouring the intervention group. A similar 
difference was maintained at follow-up (-2.0 [-3.5, -0.5] kg; P=0.010). These differences 
were accompanied by -0.8 [-1.3, -0.3] and -0.9 [-1.5, -0.3] kg∙ŵ-2 changes in BMI (P=0.002 
and P=0.002, respectively) and -1 [-2, 0] and -1 [-2, 0] % changes in body fat percentage 
(P=0.044 and P=0.033, respectively). There were no significant differences in other 
anthropometric variables. 
 
Exercise capacity 
Although data were collected for all participants, seven ISWT datasets (including ISWD and 
post-exercise RPE, SBP, DBP and HR) were excluded because participants completed the 
1020 metre test at one or more time-points (four at baseline and three at end-point). This 
ceiling effect was unexpected and dilutes the true treatment effect – consequently these 
patients were excluded from the analysis. 
Despite secure randomisation there was a large chance imbalance between groups at 
baseline for distance walked in the ISWT (475 ± 240 vs. 639 ± 198 m). Nevertheless, the 
adjusted difference in change favoured the intervention group at end-point (95 [50, 139] m; 
P<0.001) and follow-up (132 [90, 175] m; P<0.001) at follow-up. This observation occurred 
in the absence of any significant changes in any post-exercise physiological (heart rate, 
systolic blood pressure and diastolic blood pressure) or psycho-physiological (perceived 
exertion) measures (all P>0.05). 
 
Table 1: Baseline group characteristics 
  Control Intervention 
Variable n 
 
n 
 Anthropometry     
  Body mass (kg) 30 118.3 ± 21.9 30 117.4 ± 24.3 
  BodǇ ŵass iŶdeǆ ;kg∙ŵ-2) 30 39.8 ± 7.0 30 38.9 ± 6.9 
  Body fat (%) 30 40 ± 9 30 39 ± 8 
  Neck circumference (cm) 30 45 ± 5 30 44 ± 4 
  Waist circumference  (cm) 30 128 ± 14 30 125 ± 16 
  Hip circumference (cm) 30 129 ± 14 30 125 ± 15 
Cardiometabolic     
  Resting Heart rate (bpm) 30 65 ± 14 30 67 ± 11 
  Resting Systolic BP (mmHg) 30 127 ± 11 30 132 ± 15 
  Resting Diastolic BP (mmHg) 30 72 ± 8 30 75 ± 9 
  Serum cholesterol (mmol·L
-1
) 21 4.8 [3.4, 6.2] 22 4.7 [3, 6.5] 
  “eruŵ HDL ;ŵŵol∙L-1) 21 1.2 ± 0.2 22 1.3 ± 0.3 
  Cholesterol to HDL ratio 21 4.0 ± 0.7 22 4.1 ± 0.7 
  “eruŵ triglǇĐerides ;ŵŵol∙L-1) 21 1.7 [0.6, 2.8] 22 1.8 [1.2, 2.4] 
  “eruŵ LDL ;ŵŵol∙L-1) 21 2.7 ± 0.7 22 2.9 ± 1.1 
  “eruŵ CRP ;ŵg∙L-1) 21 2.9 [0.3, 5.5] 22 2 [-0.1, 4.0] 
  “eruŵ gluĐose ;ŵŵol∙L-1) 21 5.7 ± 1.6 22 5.0 ± 1.1 
  “eruŵ iŶsuliŶ ;ŵU∙L-1) 20 29 [7, 51] 20 27 [4, 50] 
ISWT 
  
 
 
  ISWD (m) 27 475 ± 240 26 639 ± 198 
  Post-ex RPE 27 15 ± 2 26 15 ± 2 
  Post-ex heart rate (bpm) 27 131 ± 28 26 148 ± 21 
  Post-ex systolic BP (mmHg) 27 169 ± 29 25 192 ± 31 
  Post-ex diastolic BP (mmHg) 27 86 ± 15 25 93 ± 11 
Quality of life     
  EuroQol EQ5D-3L VAS 30 58 ± 18 30 64 ± 17 
Data are presented as mean ± SD or median [IQR]. BP: blood pressure; HDL: high-density 
lipoprotein; LDL: low-density lipoprotein; CRP: C-reactive protein; ISWT: incremental shuttle walk 
test; ISWD: incremental shuttle walk distance; RPE: Borg rating of perceived exertion; VAS: visual 
analogue scale 
 
Biomarkers 
Nine patients were unable to provide a venous blood sample at the baseline assessment. To 
prevent potential confounding from acute inflammation, eight data sets were excluded 
ďeĐause CRP ŵeasureŵeŶt eǆĐeeded ϭϬ ŵg∙L-1 (Ridker et al., 2005). Forty-three complete 
datasets remained (21 control; 22 intervention). There was no change in serum cholesterol, 
triglycerides, HDL, LDL or glucose at endpoint or follow-up. Change in hs-CRP at end-point 
favoured the intervention group (-1.3 [-2.4, -0.2] mg⋅L-1, P=0.028), and this improvement 
was maintained at follow-up ;∆ -1.3 [-2.5, -0.1] mg⋅L-1, P=0.037). There was no evidence of 
any significant changes in serum insulin over any of the time periods. 
 
Table 2: Raw data by groups and adjusted mean differences in change at intervention end-point and follow-up.   
 
Intervention end-point 
(week 13) 
Follow-up 
(week 26) 
Variable Control Intervention 
Adjusted mean 
diff. (95% CI) 
P* Control Intervention 
Adjusted mean 
diff. (95% CI) 
P* 
Anthropometry         
  Body mass (kg) 117.9 ± 21.0 115.2 ± 24.3 -1.8 (-3.0, -0.5) 0.006 118.1 ± 21.0 115.1 ± 24.4 -2.0 (-3.5, -0.5) 0.010 
  BodǇ ŵass iŶdeǆ ;kg∙ŵ-2) 39.8 ± 6.8 38.0 ± 6.9 -0.8 (-1.3, -0.3) 0.002 39.8 ± 6.7 37.9 ± 6.9 -0.9 (-1.5, -0.3) 0.002 
  Body fat (%) 40 ± 9 37 ± 8 -1 (-2, 0) 0.044 40 ± 9 38 ± 8 -1 (-2, 0) 0.033 
  Hip circumference (cm) 128 ± 15 123 ± 15 -1 (-2, 0) 0.093 128 ± 15 122 ± 15 -2 (-3, 0) 0.020 
  Waist circumference  (cm) 127 ± 15 123 ± 16 -2 (-4, 0) 0.117 127 ± 15 123 ± 15 -2 (-4, 1) 0.143 
  Hip circumference (cm) 128 ± 15 123 ± 15 -1 (-2, 0) 0.093 128 ± 15 122 ± 15 -2 (-3, 0) 0.020 
Cardiometabolic   
  
  
  
  Resting Heart rate (beats·min
-1
) 66 ± 12 64 ± 12 -5 (-9, -2) 0.002 62 ± 9 63 ± 10 -2 (-6, 1) 0.165 
  Resting Systolic BP (mmHg) 127 ± 13 130 ± 13 0 (-5, 4) 0.893 131 ± 14 133 ± 16 -2 (-7, 4) 0.534 
  Resting Diastolic BP (mmHg) 72 ± 8 74 ± 9 -1 (-4, 2) 0.590 75 ± 8 76 ± 10 -1 (-4, 2) 0.539 
  Serum cholesterol (mmol·L
-1
) 4.8 [3.2, 6.4] 4.8 [3.5, 6.1] 0.1 (-0.2, 0.3) 0.575 4.4 [2.5, 6.3] 4.6 [3.6, 5.5] -0.1 (-0.5, 0.3) 0.645 
  “eruŵ HDL ;ŵŵol∙L-1) 1.2 ± 0.2 1.2 ± 0.3 0.0 (-0.1, 0.9) 0.569 1.2 ± 0.3 1.2 ± 0.2 -0.1 (-0.2, 0) 0.241 
  “eruŵ LDL ;ŵŵol∙L-1) 2.7 ± 0.8 2.9 ± 1 0 (-0.2, 0.3) 0.731 2.6 ± 0.9 2.8 ± 0.9 0 (-0.3, 0.3) 0.814 
  “eruŵ CRP ;ŵg∙L-1) 3.3 [0.1, 6.5] 1.4 [-0.7, 3.5] -1.3 (-2.4, -0.2) 0.028 3.2 [-2.1, 
8.5] 
1.8 [0.6, 3] -1.3 (-2.5, -0.1) 0.037 
  “eruŵ gluĐose ;ŵŵol∙L-1) 5.7 ± 1.9 4.8 ± 0.5 -0.3 (-0.9, 0.2) 0.224 5.7 ± 1.9 4.8 ± 0.8 -0.3 (-0.9, 0.3) 0.267 
ISWT   
  
  
  
  ISWD (m) 475 ± 250 724 ± 193 95 (50, 139) <0.001 471 ± 240 737 ± 179 132 (90, 175) <0.001 
Quality of life   
  
  
  
  EQVAS 63 ± 19 60 ± 20 3 (-4, 10) 0.385 69 ± 18 72 ± 16 9 (2, 16) 0.017 
Data are presented as mean ± SD or median [IQR]. BP: blood pressure; HDL: high-density lipoprotein; LDL: low-density lipoprotein; CRP: C-
reactive protein; ISWT: incremental shuttle walk test; ISWD: incremental shuttle walk distance; RPE: Borg rating of perceived exertion; EQVAS: 
EuroQol Visual Analogue Scale; *P: P-value adjusted for baseline score 
 
Quality of life 
There was a reduced proportion of participants in the intervention group reporting 
problems performing usual activities (e.g. vacuuming, cleaning and shopping) at end-point 
(P=0.044) but not follow-up (P=0.375). There were no changes in the other four EQ5D 
domains. Although there was no significant change in self-perceived health score (i.e. EQ 
visual analogue scale) at end-point, there was significant improvement at follow up of 9 [2, 
16] points (P=0.017). 
 
Discussion 
This study demonstrates that a pragmatic lifestyle intervention focussed on introducing 
structured exercise, providing dietary advice and combining both with behaviour change 
counselling improves body mass, exercise capacity and a marker of systemic inflammation in 
obese adults who were being treated with CPAP for OSAHS. The programme was well 
tolerated by patients, as exemplified by the excellent attendance rates and no reported 
adverse events (in more than 650 hours of exercise testing and training). 
Although the intervention favoured reductions in body mass aligned with our hypothesis, 
the magnitude of these changes (approx. 2 kg loss at both time-points) was small and 
possible inadequate to provide any clinical benefit. Body mass reductions in interventions 
incorporating hypoenergetic diets are typically greater (Lojander et al., 1998; Johansson et 
al., 2009) than those without (Sengul et al., 2011; Kline et al., 2011). VLEDs are often 
supplemented with psychological and dietary support, which rarely alleviates the steady 
post-intervention weight regain often observed with these interventions (Kajaste et al., 
2004; Tuomilehto et al., 2013). It is likely that the severe nature of such interventions 
produces a rapid weight loss that is unsustainable in the longer term. The intervention of 
the present study was designed and used on the premise that a pragmatic approach based 
on a slower rate of weight loss induced by making smaller changes to behaviour and 
praĐtiĐiŶg a ͞healthǇ lifestǇle͟ Đould offer ŵore sustaiŶaďle loŶg-term benefit. 
Recent meta-analyses have collated evidence on dietary interventions (Anandam et al., 
2013) and exercise-based interventions (Iftikhar et al., 2014) in OSAHS. The former reported 
a weighted mean reduction in BMI of 4.8 [3.8, 5.9] kg∙ŵ-2, and in AHI of 23.1 [8.9, 37.3] 
eǀeŶts∙h-1. The results of exercise-based interventions appeared less effective, with mean 
reductions of 1.4 [-2.8, -Ϭ.ϭ] kg∙ŵ-2 and 6.3 [-8.5, -ϰ.Ϭ] eǀeŶts∙h-1 for BMI and AHI, 
respectively (Iftikhar et al., 2014). However, these changes in BMI and AHI included a study 
(Barnes et al., 2009) that incorporated a proprietary VLED alongside the exercise 
component; this study alone had a BMI reduction almost double that of the five other 
included studies combined (-6.0 vs. -3.3 (n=5) kg∙ŵ-2) which distorted the average effect. 
Despite the greater weight loss, the improvement in AHI was smaller than 4 of the 5 other 
exercise trials. Furthermore, the Barnes et al. study was a non-controlled non-randomised 
design. The changes in BMI reported in the current study better match those in exercise-
only trials. The 15 [8, 22] and 21 [14, 27]% improvements in ISWD at end-point and follow-
up is consistent with the improvements reported by others (Barnes et al., ϮϬϬϵ; AĐkel d’Elia 
et al., 2012), and in our study comes atop of any improvement that can be observed 
through CPAP therapy alone (Billings et al., 2013).  Blair (2009) suggested that low 
cardiorespiratory fitness was attributable for a greater proportion of all-cause mortality 
(4000 deaths) than obesity, smoking and hypercholesterolaemia combined. This evidence 
amplifies the importance of improving fitness, even in the absence of changes in ͞fatŶess͟ iŶ 
clinical populations. 
Evidence suggests that addressing energy intake is more efficacious for weight loss than 
increasing energy expenditure (Shaw et al., 2006), and that exercise trials that provide 
dietary advice only are associated with smaller weight losses than those providing a VLED 
(Anandam et al., 2013; Ilfikhar et al., 2014). Although we acknowledged this when designing 
the study, we feel the severe rate of weight loss, and typical weight regain seen over time is 
not pragmatic enough for introduction into current healthcare delivery. The premise of 
making smaller changes in dietary behaviours that are more sustainable in the long term still 
merit investigation. All components of the current intervention were delivered by the same 
investigator (JM), who used psychological techniques (such as motivational interviewing) to 
elicit core behaviours and previous barriers to behaviour change in order to customise the 
intervention delivered to promote longer term adherence. 
Hs-CRP is a systemic marker of inflammation strongly associated with the atherosclerotic 
plaque development, cardiovascular disease risk and death. Our intervention demonstrated 
a significant improvement in hs-CRP at end-point (-1.3 ŵg∙L-1) that was maintained at 
follow-up. It has been shown previously that circulating CRP is elevated in OSAHS and that 
effective CPAP therapy can normalise this augmentation (Yokoe et al., 2003). Furthermore, 
there is evidence to suggest that exercise can have a beneficial effect on hs-CRP 
concentration in humans (Stewart et al., 2007). As our patients were already compliant with 
CPAP therapy, any further reductions in CRP could reflect further decrements in 
cardiovascular disease risk and progression. 
Improvements in exercise capacity were not surprising findings considering the design of 
our study. The key finding here was that after 13 weeks of independence, improvements in 
exercise capacity were not only maintained, but further improved upon. Although we 
included no measure of exercise behaviour during the independence period, further 
improvements are probably reflective of continued regular exercise training, which was 
mentioned anecdotally by participants during assessments.  
 
Limitations 
Although a metric of OSAHS severity was not included in the current study for financial and 
logistical reasons, it was thought that improvements in body mass could be a surrogate 
marker for improvements in OSAHS severity. Improvements in OSAHS in the absence of 
weight loss have been demonstrated by other groups; coupled with evidence that sedentary 
behaviour and low cardiorespiratory fitness could pose a greater public health concern than 
obesity, suggest that the improvements in exercise capacity demonstrated in the current 
study should not be underestimated. Although the current study is powered for changes in 
body mass, we do not know if it was adequately powered for the secondary outcome 
measures, so these must be interpreted with caution. Other limitations include the single-
centre study design and non-blinded assessments, which were unavoidable because of 
resource limitation. However, we have demonstrated a patient acceptable and deliverable 
programme with positive outcomes that should, in combination with enhanced dietary 
intervention, be further investigated in a larger OSA group. 
 
Conclusion 
A pragmatic lifestyle intervention in OSAHS has been shown to improve cardiometabolic 
outcomes in obese adults treated with CPAP for OSAHS. Its pragmatic approach is one that 
could be deliverable within the UK (and other) healthcare systems. Further research is 
required to further investigate the clinical- and cost-effectiveness of pragmatic lifestyle 
interventions in OSAHS. 
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